Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Other Non Operating Income: 2020-2025

Historic Other Non Operating Income for iSpecimen (ISPC) over the last 6 years, with Sep 2025 value amounting to $47,216.

  • iSpecimen's Other Non Operating Income fell 82.62% to $47,216 in Q3 2025 from the same period last year, while for Sep 2025 it was $803,251, marking a year-over-year increase of 110.24%. This contributed to the annual value of $406,181 for FY2024, which is 1138.72% up from last year.
  • As of Q3 2025, iSpecimen's Other Non Operating Income stood at $47,216, which was down 93.82% from $764,165 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Other Non Operating Income ranged from a high of $764,165 in Q2 2025 and a low of -$3.0 million during Q1 2021.
  • Its 3-year average for Other Non Operating Income is $106,923, with a median of $20,082 in 2023.
  • As far as peak fluctuations go, iSpecimen's Other Non Operating Income tumbled by 542.15% in 2023, and later spiked by 61,954.70% in 2024.
  • iSpecimen's Other Non Operating Income (Quarterly) stood at -$93,950 in 2021, then spiked by 103.35% to $3,148 in 2022, then surged by 537.93% to -$29,931 in 2023, then skyrocketed by 80.55% to -$5,821 in 2024, then plummeted by 82.62% to $47,216 in 2025.
  • Its Other Non Operating Income stands at $47,216 for Q3 2025, versus $764,165 for Q2 2025 and -$2,309 for Q1 2025.